Researchers from the Institute of Science Tokyo have developed CeSPIACE, a peptide inhibitor that blocks SARS-CoV-2 from ...
The lack of available medications in the United States for COVID post-exposure prophylaxis leaves household members in close ...
An alternative to Paxlovid, the only antiviral pills approved by the US Food and Drug Administration to treat COVID-19, is on ...
Scientists have learned more about how SARS-CoV-2 infections, which cause COVID-19, can ruin the ability of immune cells to ...
A drug called ensitrelvir can help prevent Covid-19 in people who have been exposed within households. This finding comes from an international clinical trial a UVA School of Medicine professor helped ...
The New Normal Five years ago, COVID-19 was declared a global pandemic, marking the official onset of a healthcare crisis ...
Ensitrelvir PEP was safe and effective for COVID-19 prevention among household contacts when administered after the onset of symptoms in an index patient.
The virus that causes COVID-19 continues to mutate. Scientists say that's likely to continue indefinitely, and the virus will ...
Additionally, certain SARS-CoV-2 viral variants may emerge that have substantially reduced ... that circumstances exist justifying the authorization of the emergency use of drugs and biological ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results